During the first ten years after the discovery of AIDS, the disease kept ahead of medical science's ability to fight it. Now, well into the second decade, advances in treatment are outstripping our ability to pay for them. This weekend at the University of Warwick, a group of AIDS specialists and clinical researchers from the British HIV Association (BHIVA) will issue new treatment guidelines to help doctors make sense of the confusing array of HIV drugs that are now available. The guidelines, which will be published simultaneously in The Lancet, are vague because experts differ widely on the use of these largely experimental drugs.
展开▼
